Results 91 to 100 of about 112,825,263 (146)
No Simple Fluke: Schistosomiasis as an Emerging Regulator of Haematopoiesis
ABSTRACT Schistosomiasis, or bilharzia, is a highly prevalent water‐borne helminth infection that accounts for an estimated 1.5–1.7 billion disability‐adjusted life years lost annually. Pathology driven by adult worms and eggs is accompanied by robust immunomodulation in the human host. Protective responses may promote worm elimination, limit bystander
Shinjini Chakraborty
wiley +1 more source
WH‐peptide‐functionalised liposomes encapsulating STING or RIG‐I agonists target intra‐tumoral Clec9A+ cDC1 and pDC, triggering release of type 1 IFN, presentation of CD4 and CD8 endogenous tumor epitopes, expansion of CTL with help from CD4 T cells in spleen, and tumor cell killing.
Bijun Zeng +11 more
wiley +1 more source
Managing Autofluorescence in Spectral Flow Cytometry for Macrophage Identification in the Liver
Autofluorescence in liver tissue is heterogeneous and dynamically altered during metabolic liver disease, complicating spectral flow cytometry analysis. We provide a structured framework for identifying and handling condition‐dependent autofluorescence, demonstrating that inadequate autofluorescence correction biases macrophage quantification and ...
Sabine Daemen +5 more
wiley +1 more source
Nanobiocatalysts: Potential Applications in Biofuel Production and Biotransformation
The application of nanobiocatalysts in the field of biofuel production and the biotransformation of substrate were reviewed. Further, the possible research gaps in the field of biofuel and value‐added compound production and a possible way to enhance the application of nanobiocatalyst in future development are highlighted.
Preethi Muthu +4 more
wiley +1 more source
Background: Sickle cell disease (SCD) is a condition characterized by a prothrombotic state attributed to the simultaneous activation of hemostasis and innate immunity, referred to as thromboinflammation.
Ivanio Teixeira Borba-Junior +8 more
doaj +1 more source
C-type lectin-like receptor 2 (CLEC-2)-dependent DC migration is controlled by tetraspanin CD37
Cell migration is central to evoke a potent immune response. Dendritic cell (DC) migration to lymph nodes is dependent on the interaction of C-type lectin-like receptor 2 (CLEC-2) expressed by DCs, with podoplanin expressed by lymph node stromal cells ...
Carl G Figdor +12 more
core +1 more source
The platelet aggregation-inducing factor Aggrus, also known as podoplanin, is frequently upregulated in several types of tumors and enhances hematogenous metastasis by interacting with and activating the platelet receptor CLEC-2.
Satoshi Takagi +7 more
doaj +1 more source
Antibody-mediated depletion of human CLEC-2 in a novel humanised mouse model
Platelet C-type lectin-like receptor 2 (CLEC-2) has been proposed as a potential anti-thrombotic target as genetic or antibody-mediated receptor deficiency prevents occlusive thrombus formation in mice.
Di, Ying +21 more
core +1 more source
Level of podoplanin expression in HeLa cells and the purity of the Fc-CLEC-2 fusion protein.
(A) Western blot analysis of podoplanin expression levels in pod-HeLa cells, parental HeLa cells, and TE11 cells. Triton X-100-soluble fractions from the indicated cells (4 μg or 20 μg) were analyzed by western blot for podoplanin expression levels.
Yusuke Suzuki (525707) +10 more
core +1 more source

